Arzneiwerk AG VIDA (FRA:TLIK)
Germany · Delayed Price · Currency is EUR 0.2480
+0.0440 (21.57%)
Aug 7, 2026, 11:10 AM CET
Arzneiwerk AG VIDA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.03 | 0.07 | 0.21 | 1.31 | 73.37 | 2.52 | |
Revenue Growth | - | -66.91% | -84.20% | -98.21% | 2811.37% | -10.58% |
Cost of Revenue | - | - | 0 | 0.22 | 70.33 | 0.5 |
Gross Profit | 0.03 | 0.07 | 0.21 | 1.1 | 3.05 | 2.02 |
Selling, General & Admin | 0.08 | 0.09 | 0.17 | 1.22 | 2.8 | 1.48 |
Other Operating Expenses | 0.17 | 0.3 | 0.64 | 1.73 | 1.4 | 0.84 |
Operating Expenses | 0.24 | 0.39 | 0.82 | 2.96 | 20.74 | 2.34 |
Operating Income | -0.21 | -0.32 | -0.62 | -1.87 | -17.7 | -0.32 |
Interest Expense | -0.2 | -0.19 | -0.16 | -0.05 | -0.33 | -0 |
Interest & Investment Income | 0 | 0 | - | 0.01 | 0 | 0 |
Currency Exchange Gain (Loss) | - | - | -0 | -0.01 | 0.01 | -0 |
Other Non Operating Income (Expenses) | -0.08 | -0.08 | -0.08 | 0.02 | 0 | 0.05 |
EBT Excluding Unusual Items | -0.49 | -0.6 | -0.85 | -1.89 | -18.02 | -0.27 |
Gain (Loss) on Sale of Investments | - | - | - | -0.01 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.03 | - |
Other Unusual Items | 0.03 | 0.03 | 0.01 | - | - | - |
Pretax Income | -0.46 | -0.56 | -0.84 | -1.89 | -17.99 | -0.27 |
Income Tax Expense | - | - | - | -0 | -1.05 | 0 |
Earnings From Continuing Operations | -0.46 | -0.56 | -0.84 | -1.89 | -16.94 | -0.27 |
Earnings From Discontinued Operations | - | - | - | - | 0.31 | - |
Net Income | -0.46 | -0.56 | -0.84 | -1.89 | -16.64 | -0.27 |
Net Income to Common | -0.46 | -0.56 | -0.84 | -1.89 | -16.64 | -0.27 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change | - | - | - | - | - | 42.65% |
EPS (Basic) | -0.07 | -0.09 | -0.13 | -0.30 | -2.67 | -0.04 |
EPS (Diluted) | -0.07 | -0.09 | -0.13 | -0.30 | -2.67 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -0.59 | -0.47 | -0.86 | -1.34 | -0.69 | -0.33 |
Free Cash Flow Per Share | -0.10 | -0.08 | -0.14 | -0.21 | -0.11 | -0.05 |
Gross Margin | 100.00% | 100.00% | 99.96% | 83.54% | 4.15% | 80.19% |
Operating Margin | -751.17% | -473.71% | -297.43% | -142.41% | -24.12% | -12.72% |
Profit Margin | -1619.42% | -822.63% | -403.46% | -144.39% | -22.68% | -10.62% |
Free Cash Flow Margin | -2084.21% | -688.99% | -412.96% | -101.92% | -0.94% | -13.11% |
EBITDA | -0.21 | -0.32 | -0.61 | -1.85 | -1.55 | -0.29 |
EBITDA Margin | - | - | -294.32% | -141.26% | -2.11% | -11.59% |
D&A For EBITDA | 0 | 0 | 0.01 | 0.02 | 16.15 | 0.03 |
EBIT | -0.21 | -0.32 | -0.62 | -1.87 | -17.7 | -0.32 |
EBIT Margin | - | - | -297.43% | -142.41% | -24.12% | -12.72% |
Revenue as Reported | - | - | - | 1.67 | - | - |